• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Interferon Gamma Receptor Chain 1, Neutralizing (IFNGR1) Antibody – Goat Polyclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS618765

MBS618765 is an antibody targeting IFNGR1. Also known as Interferon gamma Receptor Chain 1, neutralizing (CDw119, IFNgR1) (Biotin). Reactive in Human. Host: Goat. More details

$1125 / 0.05 mg +1 FREE 8GB USB
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Interferon gamma Receptor Chain 1, neutralizing (IFNGR1), Polyclonal Antibody
Full Product Name
Interferon gamma Receptor Chain 1, neutralizing (CDw119, IFNgR1) (Biotin)
Product Gene Name
Product Synonym Names
Anti -Interferon gamma Receptor Chain 1, neutralizing (CDw119, IFNgR1) (Biotin)
Clonality
Polyclonal
Isotype
IgG
Host
Goat
Species Reactivity
Human
Form/Format
Supplied as a liquid in Tris-buffered saline pH 7.2 (20mM Tris base,
Purity/Purification
Affinity Purified
Purified by immunoaffinity chromatography.
Specificity
Binds to and neutralizes human Interferon gamma receptor 1, 15.756kD. Blocks cell surface human human Interferon gamma receptor 1-mediated bioactivity of recombinant human Interferon gamma receptor 1. In direct ELISA and Western Blot, does not crossreact with human Interferon gamma receptor chain2.
Preparation and Storage
May be stored at 4 degree C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and add glycerol (40-50%). Freeze at -20 degree C. Aliquots are stable for at least 6 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Molecular Weight
54,405 Da
Chromosome Location
Chromosome: 6; NC_000006.11 (137518621..137540567, complement). Location: 6q23.3
OMIM
107470
3D Structure
ModBase 3D Structure for P15260
Immunogen
Recombinant, human Interferon gamma receptor chain 1, NS0-derived, extracellular domain
Endotoxin Level
< 10ng/mg

Product Categories/Family for anti-IFNGR1 antibody

Applications Tested/Suitable for anti-IFNGR1 antibody
ELISA (EL/EIA), Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC), Immunocytochemistry (ICC), Immunofluorescence (IF), Neutralization
Application Notes for anti-IFNGR1 antibody
Suitable for use in ELISA, Western Blotting, Immunoprecipitation, Immunohistochemistry, Immunofluorescence, Immunocytochemistry.
Dilution: Neutralization of Human IFN-g R1 Bioactivity:
The exact concentration of antibody required to neutralize rhIFN-g R1-mediated bioactivity is dependent on the cytokine concentration, cell type, growth conditions and the type of activity studied. The Neutralization Dose50 (ND50) for this antibody is defined as that concentration of antibody required to yield one-half maximal inhibition of the cytokine activity on a responsive cell line, when that cytokine is present at a concentration just high enough to elicit a maximum response.
The ND50 is ~0.5-2ug/ml in the presence of 2ng/ml of rhIFN-g, using a confluent culture of HeLa cells.
ELISA: 0.5-1ug/ml. Direct ELISA. The detection limit for rhIFN-g R1 is ~0.3ng/well.
Immunohistochemistry: 15ug/ml. Detects IFN-g R1 in human PBMC (peripheral blood mononuclear cells)'s (Fluorescence immunocytochemistry.
Western Blot: 0.1-0.2ug/ml. The detection limit for is ~5ng/lane under non-reducing and reducing conditions.

Other Notes

Small volumes of anti-IFNGR1 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Additional Details

NCBI/Uniprot data below describe general gene information for IFNGR1. It may not necessarily be applicable to this product.

NCBI GI #
NCBI GeneID
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
NCBI Official Full Name
Interferon gamma receptor 1
NCBI Official Synonym Full Names
interferon gamma receptor 1
NCBI Official Symbol
IFNGR1
NCBI Official Synonym Symbols
CD119; IFNGR; FLJ45734
UniProt Protein Name
Interferon gamma receptor 1
UniProt Synonym Protein Names
CDw119
UniProt Gene Name
IFNGR1
UniProt Entry Name
INGR1_HUMAN
NCBI Protein Information
interferon gamma receptor 1; CDw119; AVP, type 2; IFN-gamma-R1; CD119 antigen; OTTHUMP00000017285; OTTHUMP00000017286; IFN-gamma receptor 1; antiviral protein, type 2; immune interferon receptor 1; interferon-gamma receptor alpha chain

NCBI Summary for IFNGR1

This gene (IFNGR1) encodes the ligand-binding chain (alpha) of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. A genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection. In addition, defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease, also known as familial disseminated atypical mycobacterial infection. [provided by RefSeq]
Show more

UniProt Comments for IFNGR1

IFNGR1: Receptor for interferon gamma. Two receptors bind one interferon gamma dimer. Defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease (MSMD); also known as familial disseminated atypical mycobacterial infection. This rare condition confers predisposition to illness caused by moderately virulent mycobacterial species, such as Bacillus Calmette-Guerin (BCG) vaccine and environmental non-tuberculous mycobacteria, and by the more virulent Mycobacterium tuberculosis. Other microorganisms rarely cause severe clinical disease in individuals with susceptibility to mycobacterial infections, with the exception of Salmonella which infects less than 50% of these individuals. The pathogenic mechanism underlying MSMD is the impairment of interferon-gamma mediated immunity whose severity determines the clinical outcome. Some patients die of overwhelming mycobacterial disease with lepromatous-like lesions in early childhood, whereas others develop, later in life, disseminated but curable infections with tuberculoid granulomas. MSMD is a genetically heterogeneous disease with autosomal recessive, autosomal dominant or X-linked inheritance. Belongs to the type II cytokine receptor family.

Protein type: Receptor, cytokine; Membrane protein, integral

Chromosomal Location of Human Ortholog: 6q23.3

Cellular Component: endoplasmic reticulum; integral to plasma membrane; dendrite; postsynaptic density; integral to membrane; plasma membrane; vesicle

Molecular Function: hematopoietin/interferon-class (D200-domain) cytokine receptor activity; protein binding; interferon-gamma receptor activity; cytokine binding

Biological Process: response to virus; cytokine and chemokine mediated signaling pathway; signal transduction

Disease: Helicobacter Pylori Infection, Susceptibility To; Immunodeficiency 27b; Immunodeficiency 27a; Mycobacterium Tuberculosis, Susceptibility To; Hepatitis B Virus, Susceptibility To
Show more

Precautions

All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.

Disclaimer

While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.

Product Note

Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.

Product PubMed Publications

Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000